Variations in glycoprotein IIb-IIIa (αIIb/β3-integrin) content in healthy donors. Influence on platelet aggregation activity and efficacy of aspirin action

Biomeditsinskaya Khimiya

Volumn 54, Issue 3, 2008, Pages 361-371

  Khaspekova, S G ^a   Sirotkina, O V ^b   Shimanova, Y V ^a   Mazurov, A V ^a  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^b PETERSBURG NUCLEAR PHYSICS INSTITUTE   (Russian Federation)

Author keywords

Fibrinogen; Genetic polymorphism; Glycoprotein IIb IIIa; Integrins; Platelets

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; FIBRINOGEN; FIBRINOGEN RECEPTOR;

ARTICLE; DRUG EFFECT; GENETIC POLYMORPHISM; GENETICS; HUMAN; METABOLISM; REFERENCE VALUE; THROMBOCYTE; THROMBOCYTE AGGREGATION;

ASPIRIN; BLOOD PLATELETS; FIBRINOGEN; HUMANS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; POLYMORPHISM, GENETIC; REFERENCE VALUES;

EID: 51249091035     PISSN: 23106905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Quinn M.J., Byzova T.V., Qin J., Topol E.J., Plow E.F. (2003) Arterioscler. Thromb. Vasc Biol., 23, 945-952.
2. Thcheng J.E., Ellis S.G., George B.S., Kereiakes D.J., Kleiman NS, Talley J.D., Wang A.L., Weisman H.F., Califf R.M., Topol E.J. (1994) Circulation, 90, 1757-1764.
3. Mazurov A.V., Pevzner D.V., Antonova O.A., Byzova T.V., Khaspekova S.G., Semenov A.V., Vlasik T.N., Samko A.N., Staroverov I.I., Ruda M.Ya. (2002) Platelets 13, 465-477.
4. Newman PJ, Derbes RS, Aster R.H. (1989) J. Clin. Invest., 83, 1778-1781.
5. Kunicki T.J., Newman P.J. (1992) Blood, 80, 1386-1404.
6. Feng D., Lindpaintner K., Larson M.G., Rao VS., O'Donnell C.J., Lipinska I., Schmitz C., Sutherland P.A., Silbershatz H., D'Agostino R.B., Muller J.E., Myers R.H., Levy D., Tofler G.H. (1999) Artherioscler. Thromb. Vasc. Biol., 19, 1142-1147.
7. Russian source
8. Weiss E.J., Bray P.F., Tayback M., Schulman S.P., Kickler T.S., Becker L.C., Weiss J.L., Gerstenblith G., Goldschmidt-Clermont P.J. (1996) N. Engl. J. Med., 334, 1090-1094.
9. Byzova T.V., Plow E.F. (2000) J. Clin. Invest., 105, 697-698.
10. Di Castelnuovo A., de Gaetano G., Benedetto Donati M., Iacoviello L. (2005) Am. J. Pharmacogenomics, 5, 93-99.
11. Vijayan K.V., Goldschmidt-Clermont P.J., Roos C., Bray P.F. (2000) J Clin Invest, 105, 793-802.
12. Goodall A.H., Curzen N., Panesar M., Hurd C., Knight C.J., Ouwehand W.H., Fox K.M. (1999) Eur. Heart J., 20, 742-747.
13. Michelson A.D., Furman M.I., Goldschmidt-Clermont P., Mascelli M.A., Hendrix C., Coleman L., Hamlington J., Barnard M.C., Kickler T., Christie D.J., Kundu S., Bray P.F. (2000) Circulation, 101, 1013-1018.
14. Bennett J.S., Catella-Lawson F., Rut A.R., Vilaire G., Qi W., Kapoor S.C., Murphy S., FitzGerald G.A. (2001) Blood, 97, 3093-3099.
15. Lasne D., Krenn M., Pingault V., Arnaud E., Fiessinger J.N., Aiach M., Rendu F. (1997) Br. J. Haematol., 99, 801-807.
16. Andrioli G., Minuz P., Solero P., Pincelli S., Ortolani R., Lussignoli S., Bellavite P. (2000) Br. J. Haematol., 110, 911-918.
17. Frey U.H., Aral N., Muller N., Siffert W. (2003) Thromb. Res., 109, 279-286.
18. Aalto-Setalo K., Karhunen P.J., Mikkelsson J., Niemela K. (2005) J. Thromb. Thrombolysis, 20, 57-63.
19. Feng D., Lindpaintner K., Larson M.G., O'Donneil C.J., Lipinska I., Sutherland P.A., Mittleman M., Muller J.E., D'Agostino R.B., Levy D., Tofler G.M. (2001) Circulation, 104, 140-144.
20. Meade T.W., Vickers M.V., Thompson S.G., Stirling Y., Haines A. P, Miller G.J. (1985) Br. Med. J., 290, 428-432.
21. Russian source
22. Khaspekova S.G., Vlasik T.N., Byzova T.V., Vinogradov D.V., Berndt M.C., Mazurov A.V. (1993) Br. J. Haematol., 85, 332-340.
23. Patrono C., Coller B., Dalen J.E., Fitzgerald G.A., Fuster V., Gent M., Hirsh J., Roth G. (2001) Chest, 199 (Suppl), 39S-63S.
24. Russian source
25. Hankey G.J., Eikelboom J.W. (2004) Br. Med. J., 328, 477-479.